Magenta Therapeutics to Participate in Upcoming Healthcare Investor Conferences in May
Magenta Therapeutics (Nasdaq: MGTA) has announced that its CEO, Jason Gardner, will participate in fireside chats at two investor conferences this month. These events are the Cowen 2nd Annual Virtual Oncology Innovation Summit on May 20 at 10:40 a.m. ET and the Oppenheimer Rare & Orphan Disease Summit on May 21 at 2:55 p.m. ET. Interested parties can access live webcasts on the company's website, with replays available for 90 days post-event. Magenta aims to advance stem cell transplant therapies for various blood cancers and genetic diseases.
- None.
- None.
Magenta Therapeutics (Nasdaq: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of stem cell transplants to more patients, today announced that Jason Gardner, D.Phil., President and Chief Executive Officer, will participate in fireside chats at the following investor conferences this month:
- Cowen 2nd Annual Virtual Oncology Innovation Summit on Thursday, May 20, at 10:40 a.m. ET
- Oppenheimer Rare & Orphan Disease Summit on Friday, May 21, at 2:55 p.m. ET
Live webcasts of the fireside chats can be accessed on the Magenta Therapeutics website at https://investor.magentatx.com/events-and-presentations. The webcast replays will be available for 90 days following each event.
About Magenta Therapeutics
Magenta Therapeutics is a clinical-stage biotechnology company developing medicines to bring the curative power of stem cell transplant to more patients with blood cancers, genetic diseases and autoimmune diseases. Magenta is combining leadership in stem cell biology and biotherapeutics development with clinical and regulatory expertise, a unique business model and broad networks in the stem cell transplant community to revolutionize immune reset for more patients.
Magenta is based in Cambridge, Mass. For more information, please visit www.magentatx.com.
Follow Magenta on Twitter: @magentatx.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210514005057/en/
FAQ
When will Jason Gardner participate in the Cowen 2nd Annual Virtual Oncology Innovation Summit?
What is the date of the Oppenheimer Rare & Orphan Disease Summit?
How can I access the webcasts of Magenta Therapeutics' investor conferences?
What is the focus of Magenta Therapeutics?
Where is Magenta Therapeutics based?
